Previous studies reported that compared with NMM, the expression levels of SNAI2 [21–23], MMP2 [24–26], MIF [27–29], and AP1S2 [30] were up-regulated in MM and were crucial roles in the metastasis and malignant progression of melanoma. The gene discussed is SNAI2; the disease is Miyoshi myopathy.